Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
99mtc mip 1404 (1 trial)
docetaxel (taxotere) (1 trial)
sepantronium (1 trial)
Breast Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (3 total)